| Primary |
| Chest Pain |
15.1% |
| Product Used For Unknown Indication |
12.7% |
| Angina Pectoris |
11.3% |
| Hypertension |
8.6% |
| Coronary Artery Disease |
7.9% |
| Blood Pressure Increased |
5.1% |
| Arteriospasm Coronary |
4.8% |
| Cardiac Disorder |
3.8% |
| Drug Use For Unknown Indication |
3.8% |
| Cardiac Failure |
3.4% |
| Heparin Neutralisation Therapy |
2.7% |
| Hypotension |
2.7% |
| Electrolyte Substitution Therapy |
2.4% |
| Essential Hypertension |
2.4% |
| Haemorrhage Prophylaxis |
2.4% |
| Ill-defined Disorder |
2.4% |
| Pain |
2.4% |
| Anal Fissure |
2.1% |
| Diabetes Mellitus |
2.1% |
| Induction Of Anaesthesia |
2.1% |
|
| Syncope |
16.6% |
| Hypotension |
11.2% |
| Drug Ineffective |
8.3% |
| Presyncope |
6.5% |
| Vomiting |
6.5% |
| Completed Suicide |
5.3% |
| Pruritus Generalised |
5.3% |
| Grand Mal Convulsion |
4.1% |
| Chest Pain |
3.6% |
| Hypertension |
3.6% |
| Medication Error |
3.6% |
| Product Quality Issue |
3.6% |
| Product Solubility Abnormal |
3.6% |
| Drug Hypersensitivity |
3.0% |
| Pharmaceutical Product Complaint |
3.0% |
| Ventricular Fibrillation |
3.0% |
| Cardiac Arrest |
2.4% |
| Drug Interaction |
2.4% |
| Headache |
2.4% |
| Loss Of Consciousness |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
29.9% |
| Drug Use For Unknown Indication |
16.8% |
| Hypertension |
10.7% |
| Pain |
6.7% |
| Angina Pectoris |
4.6% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Multiple Myeloma |
3.1% |
| Chest Pain |
2.7% |
| Anaesthesia |
2.6% |
| Diabetes Mellitus |
2.6% |
| Cardiac Disorder |
2.5% |
| Asthma |
2.2% |
| Coronary Artery Disease |
1.6% |
| Prinzmetal Angina |
1.6% |
| Atrial Fibrillation |
1.6% |
| Rheumatoid Arthritis |
1.5% |
| Hypercholesterolaemia |
1.4% |
| Prophylaxis |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Supplementation Therapy |
1.3% |
|
| Completed Suicide |
19.0% |
| Syncope |
13.3% |
| Renal Failure |
6.0% |
| Nausea |
5.6% |
| Renal Failure Acute |
5.6% |
| Ventricular Tachycardia |
5.2% |
| Stevens-johnson Syndrome |
4.4% |
| Death |
4.0% |
| Vision Blurred |
4.0% |
| Muscular Weakness |
3.6% |
| Hypertension |
3.2% |
| Loss Of Consciousness |
3.2% |
| Overdose |
3.2% |
| Toxicity To Various Agents |
3.2% |
| Cerebrovascular Accident |
2.8% |
| Headache |
2.8% |
| Hypotension |
2.8% |
| Myocardial Infarction |
2.8% |
| Fall |
2.4% |
| Mental Disorder |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.2% |
| Drug Use For Unknown Indication |
23.0% |
| Hypertension |
7.2% |
| Pain |
3.4% |
| Coronary Artery Bypass |
3.3% |
| Diabetes Mellitus |
3.0% |
| Angina Pectoris |
2.9% |
| Cardiac Disorder |
2.8% |
| Chest Pain |
2.6% |
| Prophylaxis |
1.9% |
| Depression |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Atrial Fibrillation |
1.6% |
| Rheumatoid Arthritis |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Osteoporosis |
1.4% |
| Multiple Myeloma |
1.4% |
| Coronary Artery Disease |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Vomiting |
10.9% |
| Myocardial Infarction |
10.6% |
| Pain |
9.0% |
| Weight Decreased |
6.9% |
| Unevaluable Event |
6.1% |
| Weight Increased |
6.0% |
| Injury |
5.9% |
| Renal Failure |
5.7% |
| Death |
5.0% |
| Renal Failure Acute |
4.0% |
| Fear |
3.5% |
| Anxiety |
3.5% |
| Nausea |
3.2% |
| Anhedonia |
3.2% |
| Urinary Tract Infection |
3.1% |
| Syncope |
2.9% |
| Pneumonia |
2.7% |
| Stress |
2.7% |
| Vision Blurred |
2.6% |
| Chest Pain |
2.6% |
|
| Interacting |
| Hypertension |
22.5% |
| Cardiac Disorder |
12.5% |
| Product Used For Unknown Indication |
10.8% |
| Chest Pain |
5.0% |
| Insomnia |
5.0% |
| Nervous System Disorder |
5.0% |
| Anticoagulant Therapy |
3.3% |
| Coronary Artery Disease |
3.3% |
| Diabetes Mellitus |
3.3% |
| Dyspnoea |
3.3% |
| Infarction |
3.3% |
| Myocardial Ischaemia |
3.3% |
| Pulmonary Hypertension |
3.3% |
| Anxiety |
2.5% |
| Delirium |
2.5% |
| Gastrointestinal Disorder |
2.5% |
| Ischaemic Cardiomyopathy |
2.5% |
| Nervousness |
2.5% |
| Abnormal Behaviour |
1.7% |
| Angina Pectoris |
1.7% |
|
| Vision Blurred |
13.8% |
| Drug Interaction |
10.3% |
| Medication Error |
10.3% |
| Rhabdomyolysis |
10.3% |
| Hyperkalaemia |
6.9% |
| Off Label Use |
6.9% |
| Syncope |
6.9% |
| Diarrhoea |
3.4% |
| Discomfort |
3.4% |
| Dyspnoea |
3.4% |
| Extrasystoles |
3.4% |
| Labelled Drug-drug Interaction Medication Error |
3.4% |
| Loss Of Consciousness |
3.4% |
| Nausea |
3.4% |
| Phosphenes |
3.4% |
| Respiratory Distress |
3.4% |
| Thinking Abnormal |
3.4% |
|
